Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk..
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cgh.2018.11.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!